Hyperglycaemia, adverse outcomes and impact of intravenous insulin therapy in patients presenting with acute ST-elevation myocardial infarction in a socioeconomically disadvantaged urban setting: The Montefiore STEMI Registry.
Sanyog G ShitoleVankeepuram SrinivasJulia L BerkowitzTina ShahMichael J ParkSamuel HerzigAnne ChristianNeeral PatelXiaonan XueJames ScheuerJorge R KizerPublished in: Endocrinology, diabetes & metabolism (2019)
Pronounced hyperglycaemia was common and associated with adverse prognosis in this urban population. CIIT met with selective use and was associated with hypoglycaemia, together with increased mortality at specific time points. Given the burden of metabolic disease, particularly among race-ethnic minorities, assessing the benefits of CIIT is a prerogative that requires evaluation in large-scale randomized trials.
Keyphrases
- st elevation myocardial infarction
- percutaneous coronary intervention
- type diabetes
- liver failure
- st segment elevation myocardial infarction
- cardiovascular events
- acute coronary syndrome
- respiratory failure
- risk factors
- coronary artery disease
- glycemic control
- aortic dissection
- stem cells
- drug induced
- cardiovascular disease
- emergency department
- atrial fibrillation
- low dose
- cell therapy
- adipose tissue
- intensive care unit
- adverse drug
- extracorporeal membrane oxygenation